You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

779 Results
Document
Dec 2021
Document
Dec 2021
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Myeloid (AML)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    gilteritinib - Relapsed or Refractory FLT3-mutated acute myeloid leukemia
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
gilteritinib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Mar 2022
Document
Jan 2022
Document
Jan 2022
Document
Feb 2022
Document
Feb 2022
Drug
Other Name(s): Xospata®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jul 2023
Document
Mar 2022

Pages